Targeting the role of N-terminal methionine processing enzymes in Mycobacterium tuberculosis

Tuberculosis

Volumn 89, Issue SUPPL.1, 2009, Pages

  Olaleye, Omonike A ^b   Bishai, William R ^a   Liu, Jun O ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Methionine aminopeptidase (MetAP); Mycobacterium tuberculosis (Mtb); N Terminal methionine excision (NME); Peptide deformylase (PDF); Tuberculosis (TB)

Indexed keywords

ANTIMYCOBACTERIAL AGENT; BACTERIAL ENZYME; METHIONYL AMINOPEPTIDASE; PEPTIDE DEFORMYLASE;

ARTICLE; BACTERIAL STRAIN; DRUG TARGETING; ENZYME ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; SUPERINFECTION; TUBERCULOSIS;

AMIDOHYDROLASES; AMINOPEPTIDASES; ANTITUBERCULAR AGENTS; DRUG DISCOVERY; HUMANS; MYCOBACTERIUM TUBERCULOSIS;

EID: 72049124267     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-9792(09)70013-7     Document Type: Article

References (63)

1. Fauci A.S., and NIAID TB Working group. Multidrug-resistant and extensively drug-resistant tuberculosis. Perspective JID 197 (2008) 1493-1498
2. Spigelman M.K. New tuberculosis therapeutics: A growing pipeline. JID 196 Suppl 1 (2007) S28-S34
3. WHO declares TB an emergency in Africa: Call for "urgent and extraordinary actions" to halt worsening epidemic. WHO Media centre News (2005)
4. Raviglione M.C. The TB epidemic from 1992 to 2002. Tuberculosis 83 (2003) 4-14
5. National Institute of Allergy and Infectious Diseases. Tuberculosis health matters. Facts sheets and brochure (2002)
6. Zhang Y. The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 45 (2005) 529-564
7. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 (1998) 537-544
8. Giglione C., Boularot A., and Meinnel T. Protein N-terminal methionine excision. Cell Mol Life Sci 61 (2004) 1455-1474
9. Giglione C., Vallon O., and Meinnel T. Control of protein life-span by N-terminal methionine excision. EMBO J 22 (2003) 13-23
10. Spellberg B., Powers J.H., Brass E.P., Miller L.G., and Edwards Jr. J.E. Trends in antimicrobial drug development: Implications for the future. Clin Infect Dis 38 (2004) 1279-1286
11. Miesel L., Greene J., and Black T. Genetic strategies for antibacterial drug discovery. Nat Rev Genet 4 (2003) 442-456
12. Andries K., Verhasselt P., Guillemont J., Gohlmann H.W., Neefs J.M., Winkler H., et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307 (2005) 223-227
13. Petrella S., Cambau E., Chauffor A., Andries K., Jarlier V., and Sougakoff W. Genetic basis for natural and acquired resistance to the diarylquinoline r207910 in mycobacteria. Antimicrob Agents Chemother 50 (2006) 2853-2856
14. Yuan Z., and White R.J. The evolution of peptide deformylase as a target: Contribution of biochemistry, genetics and genomics. Biochem Pharmacol 71 (2006) 1042-1047
15. Leeds J.A., and Dean C.R. Peptide deformylase as an antibacterial target: a critical assessment. Curr Opin Pharmacol 6 (2006) 445-452
16. Pichota A., Duraiswamy J., Yin Z., Keller T.H., Alam J., Liung S., et al. Peptide deformylase inhibitors of Mycobacterium tuberculosis: Synthesis, structural investigations and biological results. Bioorg Med Chem Lett 18 (2008) 6568-6572
17. Addlagatta A., Quillin M., Omotoso O., Liu J.O., and Matthews B.W. Identification of an SH3-binding motif in a new class of methionine aminopeptidases from Mycobacterium tuberculosis suggests a mode of interaction with the ribosome. Biochemistry 44 (2005) 7166-7174
18. Solbiati J., Chapman-Smith A., Miller J.L., Miller C.G., and Cronan Jr. J.E. Processing of the N-termini of nascent polypeptide chains requires deformylation prior to methionine removal. J Mol Biol 290 (1999) 607-614
19. Teo J.W., Thalayan P., Beer D., Yap A.S., Nanjundappa M., Ngew X., et al. Peptide deformylase inhibitors as potent antimycobacterial agents. Antimicrob Agents Chemother 50 (2006) 3665-3673
20. Escobar-Alvarez S., Goldgur Y., Yang G., Ouerfelli O., Li Y., and Schienberg D.A. Structure and activity of human mitochondrial peptide deformylase, a novel cancer target. J Mol Biol 387 (2009) 1211-1228
21. Boxem M., Tsai C.W., Zhang Y., Saito R.M., and Liu J.O. The C. elegans methionine amino-peptidase 2 analog map-2 is required for germ cell proliferation. FEBS Lett 576 (2004) 245-250
22. Bernier S.G., Taghizadeh N., Thompson C.D., Westlin W.F., and Hannig G. Methionine aminopepidases Type I and Type II are essential to control cell proliferation. J Cell Biochem 95 (2005) 1191-1203
23. Hu X., Addlagatta A., Lu J., Matthews B.W., and Liu J.O. Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression. PNAS 103 (2006) 18148-18153
24. Yeh J.J., Ju R., Brdlik C.M., Zhang W., Zhang Y., Matyskiela M.E., et al. Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest. PNAS 103 (2006) 10379-10384
25. Li X., and Chang Y. Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. PNAS 92 (1995) 12357-12361
26. Chang Y., Teichart U., and Smith J.A. Molecular cloning, sequencing, deletion, and overexpression of a methionine aminopeptidase gene from Saccharomyces cerevisiae. J Biol Chem 267 (1992) 8007-8011
27. Chang S.Y., McGary E.C., and Chang S. Methionine aminopeptidase gene of Escherichia coli is essential for cell growth. J Bacteriol 171 (1989) 4071-4072
28. Miller C.G., Kukral J.L., and Movva N.R. pepM is an essential gene in Salmonella typhimurium. J Bacteriol. 171 (1989) 5215-5217
29. Lowther W.T., and Matthews B.W. Structure and function of the methionine amino-peptidases. Biochim Biophys Acta 1477 (2000) 157-167
30. Arfin S.M., Kendall R.L., Hall L., Weaver L.H., Stewart A.E., Matthews B.W., et al. Eukaryotic methionyl aminopeptidases: Two classes of cobalt-dependent enzymes. PNAS 92 (1995) 7714-7718
31. Griffith E.C., Su Z., Turk B.E., Chen S., Chang Y., Wu Z., et al. Methionine amino-peptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem Biol 4 (1997) 461-471
32. Sin N., Meng L., Wang M.Q., Wen J.J., Bornmann W.G., and Crews C.M. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. PNAS 94 (1997) 6099-6103
33. WAF1/CIP1. PNAS 97 (2000) 6427-6432
34. Satchi-Fainaro R., Mamluk R., Wang L., Short S.M., Nagy J.A., Feng D., et al. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 7 (2005) 251-261
35. Satchi-Fainaro R., Puder M., Davies J.W., Tran H.T., Sampson D.A., Greene A.K., et al. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med 10 (2004) 255-261
36. Griffith E.C., Su Z., Niwayama S., Ramsay C.A., Chang Y.H., and Liu J.O. Molecular recognition of angiogenesis inhibitors Fumagillin and Ovalicin by methionine aminopeptidase 2. PNAS 95 (1998) 15183-15188
37. Turk B.E., Griffith E.C., Wolf S., Biemann K., Chang Y.H., and Liu J.O. Selective inhibition of amino-terminal processing by TNP-470 and ovalicin in endothelial cells. Chem Biol 6 (1999) 823-833
38. Chun E., Han C.K., Yoon J.H., Sim T.B., Kim Y.K., and Lee K.Y. Novel inhibitors targeted to methionine aminopeptidase 2 (MetAP2) strongly inhibit the growth of cancers in xenografted nude model. Int J Cancer 114 (2005) 124-130
39. Kruger E.A., and Figg W.D. TNP-470: An angiogenesis inhibitor in clinical development for cancer. Expert Opin Invest. Drugs 9 (2000) 1383-1396
40. Catalano A., Romano M., Robuffo I., Strizzi L., and Procopio A. Methionine aminopeptidase-2 regulates human mesothelioma cell survival: role of Bcl-2 expression and telomerase activity. Am J Pathol 159 (2001) 721-731
41. Vaughn M.D., Sampson P.B., and Honek J.F. Methionine in and out of proteins: targets for drug design. Curr Med Chem 9 (2002) 385-409
42. Endo H., Takenaga K., Kanno T., Satoh H., and Mori S. Methionine Aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4. J Biol Chem 277 (2002) 26396-26402
43. Bradshaw R.A., and Yi E. Methionine aminopeptidases and angiogenesis. Essays Biochem 38 (2002) 65-78
44. Koyanagi S., Nakagwa H., Kuramoto Y., Ohdo S., Soeda S., and Shimeno H. Optimizing the dosing schedule of TNP-470 [O-(chloroacetyl-carbamoyl) fumagillol] enhances its antitumor and antiangiogenic efficacies. J Pharmacol Exp Ther 304 (2003) 669-674
45. Wang J., Sheppard G.S., Lou P., Kawai M., BaMaung N., Erickson S.A., et al. Tumor suppression by a rationally designed reversible inhibitor of methionine amino-peptidase-2. Cancer Res 63 (2003) 7861-7869
46. Selvakumar P., Lakshmikuttyamma A., Kanthan R., Kanthan S.C., Dimmock J.R., and Sharma R.K. High expression of methionine aminopeptidase 2 in human colorectal adenocarcinomas. Clin Cancer Res 10 (2004) 2771-2775
47. Morowitz M.J., Barr R., Wang Q., King R., Rhodin N., Pawel B., et al. Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models. Clin Cancer Res 11 (2005) 2680-2685
48. Shusterman S., and Maris J.M. Prospects for therapeutic inhibition of neuroblastoma angiogenesis. Cancer Lett 228 (2005) 171-179
49. Dasgupta B., Yi Y., Hegedus B., Weber J.D., and Gutmann D.H. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. Cancer Res 65 (2005) 9843-9850
50. Hannig G., Lazarus D.D., Bernier S.G., Karp R.M., Lorusso J., Qiu D., et al. Inhibition of melanoma tumor growth by a pharmacological inhibitor of MetAP-2, PPI-2458. Int J Oncol 28 (2006) 955-963
51. Zhong H., and Bowen J.P. Antiangiogenesis drug design: multiple pathways targeting tumor vasculature. Curr Med Chem 13 (2006) 849-862
52. Cooper A.C., Karp R.M., Clark E.J., Taghizadeh N.R., Hoyt J.G., Labenski M.T., et al. A novel methionine aminopeptidase 2 inhibitor, PPI-2458, inhibits non-Hodgkin's lymphoma cell proliferation in vitro and in vivo. Clin Cancer Res 12 (2006) 2583-2590
53. Bernier S.G., Lazarus D.D., Clark E.J., Doyle B., Labenski M.T., Thompson C.D., et al. A methionine aminopeptidase-2 inhibitor, PPI-2458, for treatment of rheumatoid arthritis. PNAS 101 (2004) 10768-10773
54. Zhang P., Nicholson D.E., Bujnicki J.M., Su X., Brendle J.J., Ferdig M., et al. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis. J Biomed Sci 9 (2002) 34-40
55. Chen L.L., Li J., Li J.Y., Luo Q.L., Mao W.F., Shen Q., et al. Type I methionine amino-peptidase from Saccharomyces cerevisiae is a potential target for antifungal drug screening. Acta Pharmacol Sin 25 (2004) 907-914
56. Chen X., Chong C.R., Shi L., Yoshimoto T., Sullivan Jr. D.J., and Liu J.O. Inhibitors of Plasmodium falciparum methionine aminopeptidase Ib possess antimalarial activity. PNAS 103 (2006) 14548-14553
57. 2155. Appl Biochem Biotechnol 151 (2008) 512-521
58. Liu S., Widom J., Kemp C.W., Crews C.M., and Clardy J. Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science 282 (1998) 1324-1327
59. Hu X., Addlagatta A., Matthews B.W., and Liu J.O. Identification of pyridinylpyrimidines as inhibitors of human methionine aminopeptidases. Angew Chem Int Ed Engl 45 (2006) 3772-3775
60. Addlagatta A., Hu X., Liu J.O., and Matthews B.W. Structural basis for the functional differences between type I and type II human methionine aminopeptidases. Biochemistry 44 (2005) 14741-14749
61. Douangamath A., Dale G.E., D'Arcy A., Almstetter M., Eckl R., Frutos-Hoener A., et al. Crystal structures of Staphylococcus aureus methionine aminopeptidase complexed with keto heterocycle and aminoketone inhibitors reveal the formation of a tetrahedral intermediate. J Med Chem 47 (2004) 1325-1328
62. Oefner C., Douangamath A., D'Arcy A., Hafeli S., Mareque D., Mac Sweeney A., et al. The 1.15A crystal structure of the Staphylococcus aureus methionyl-aminopeptidase and complexes with triazole based inhibitors. J Mol Biol 332 (2003) 13-21
63. Luo Q.L., Li J.Y., Liu Z.Y., Chen L.L., Li J., Qian Z., et al. Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. J Med Chem 46 (2003) 2631-2640